AR094662A1 - USEFUL COMPOUND FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES - Google Patents

USEFUL COMPOUND FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Info

Publication number
AR094662A1
AR094662A1 ARP140100127A ARP140100127A AR094662A1 AR 094662 A1 AR094662 A1 AR 094662A1 AR P140100127 A ARP140100127 A AR P140100127A AR P140100127 A ARP140100127 A AR P140100127A AR 094662 A1 AR094662 A1 AR 094662A1
Authority
AR
Argentina
Prior art keywords
degenerative
treatment
inflammatory diseases
useful compound
solvate
Prior art date
Application number
ARP140100127A
Other languages
Spanish (es)
Original Assignee
Galapagos Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galapagos Nv filed Critical Galapagos Nv
Publication of AR094662A1 publication Critical patent/AR094662A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Un compuesto de acuerdo con la fórmula (1), o una sal farmacéuticamente aceptable o un solvato o un solvato de una sal farmacéuticamente aceptable del mismo.Claim 1: A compound according to formula (1), or a pharmaceutically acceptable salt or a solvate or a solvate of a pharmaceutically acceptable salt thereof.

ARP140100127A 2013-01-17 2014-01-14 USEFUL COMPOUND FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES AR094662A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361753482P 2013-01-17 2013-01-17

Publications (1)

Publication Number Publication Date
AR094662A1 true AR094662A1 (en) 2015-08-19

Family

ID=56117428

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140100127A AR094662A1 (en) 2013-01-17 2014-01-14 USEFUL COMPOUND FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Country Status (1)

Country Link
AR (1) AR094662A1 (en)

Similar Documents

Publication Publication Date Title
CR20150078A (en) 1,4-DISPOSED PIRIDAZINE ANALOGS AND METHODS FOR THE TREATMENT OF CONDITIONS RELATED TO THE DEFICIENCY OF SMN
CL2018000318A1 (en) Compounds derived from pyridinone, bromodomain inhibitors; pharmaceutical composition comprising them; and its use in the treatment of cancer diseases. (divisional application 201600925)
AR110381A2 (en) BIUTYL INHIBITORS OF TIROSINA CINASA DE BRUTON
DOP2020000102A (en) HELPFUL COMPOUNDS TO INHIBIT CDK7
AR094970A1 (en) AN MDM2 INHIBITOR DERIVED FROM BENZOIC ACID FOR CANCER TREATMENT
CR20150418A (en) TETRAHYDROPIRROLOTIAZINE COMPOUNDS
ES2721001T3 (en) Isoindoline derivative, and compositions and methods to treat a neurodegenerative disease
PH12016500024A1 (en) Bromodomain inhibitor
AR098274A1 (en) GRELINA INHIBITOR O-ACIL TRANSFERASA
UY36275A (en) AMINOPIRIMIDINYL COMPOUNDS
MX2016013689A (en) 4-amino-imidazoquinoline compounds.
MX2016017147A (en) Substituted indazole compounds as irak4 inhibitors.
AR106141A1 (en) METHODS AND INTERMEDIARIES FOR THE PREPARATION OF DERIVATIVES OF BILIARY ACIDS
DOP2015000201A (en) AZABENCIMIDAZOL COMPOUNDS AS INHIBITORS OF PDEN4 ISOENZIMAS FOR THE TREATMENT OF THE CNS AND OTHER DISORDERS
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
CL2016001587A1 (en) Derivative based on 1,2-naphthoquinone and method of preparation thereof.
AR095097A1 (en) PHENOXYETOXI COMPOUNDS
EA201691670A1 (en) TETRASOLONETRESSED DIHYDROPYRIDINOUM INHIBITORS MGAT2
AR105821A1 (en) USEFUL COMPOUNDS TO INHIBIT ROR-g-T
UY34615A (en) NEW USEFUL COMPOUNDS FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES.
EA201592268A1 (en) DIHYDROPYRIDINONE INHIBITORS MGAT2
EA201790687A1 (en) QUINOLINCARBOXAMIDE FOR USE IN THE TREATMENT OF MULTIPLE MYELOMA
CR20150325A (en) TRICYCLE COMPOUNDS TO INHIBIT THE CFTR CHANNEL
EA201792264A1 (en) METHODS OF TREATING INFLAMMATORY DISEASES
BR112015016033A2 (en) compositions and methods for treating bacterial infections

Legal Events

Date Code Title Description
FB Suspension of granting procedure